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DNA interstrand cross-links (ICLs) represent lethal DNA damage, because they block transcription, rep-
lication, and segregation of DNA. Because of their genotoxicity, agents inducing ICLs are often used in
antitumor therapy. The repair of ICLs is complex and involves proteins belonging to nucleotide excision,
recombination, and translesion DNA repair pathways in Escherichia coli, Saccharomyces cerevisiae, and mam-
mals. We cloned and analyzed mammalian homologs of the S. cerevisiae gene SNM1 (PSO2), which is specif-
ically involved in ICL repair. Human Snm1, a nuclear protein, was ubiquitously expressed at a very low level.
We generated mouse SNM12/2 embryonic stem cells and showed that these cells were sensitive to mitomycin
C. In contrast to S. cerevisiae snm1 mutants, they were not significantly sensitive to other ICL agents, probably
due to redundancy in mammalian ICL repair and the existence of other SNM1 homologs. The sensitivity to
mitomycin C was complemented by transfection of the human SNM1 cDNA and by targeting of a genomic
cDNA-murine SNM1 fusion construct to the disrupted locus. We also generated mice deficient for murine
SNM1. They were viable and fertile and showed no major abnormalities. However, they were sensitive to
mitomycin C. The ICL sensitivity of the mammalian SNM1 mutant suggests that SNM1 function and, by
implication, ICL repair are at least partially conserved between S. cerevisiae and mammals.
DNA interstrand cross-links (ICLs) prevent strand separa-
tion, thereby physically blocking transcription, replication, and
segregation of DNA. In bacterial and yeast cells, the presence
of one unrepaired ICL can be lethal (36, 40). Humans are
exposed to environmental ICL agents, such as furocoumarins,
from plants and cosmetics (50). Due to their extreme genotox-
icity, agents that induce cross-links in DNA are widely used in
antitumor therapy. Examples include cisplatin, mitomycin C
(MMC), and derivatives of nitrogen mustard, such as melpha-
lan and cyclophosphamide. Most of these agents cause a num-
ber of different lesions in DNA, including monoadducts, DNA-
protein cross-links, and DNA intrastrand cross-links and ICLs.
The latter are the main cause of cell death, although they
constitute only a small percentage of the total number of ad-
ducts (6, 36). Resistance of tumors to cross-linking agents can
be caused by a variety of mechanisms, including increased
repair of ICLs (1, 5, 31). Therefore, an understanding of how
ICLs are repaired is important.
To elucidate the mechanism of ICL repair in yeast, genetic
screens have been performed to find genes specifically involved
in ICL repair. A number of snm and pso mutants have been
isolated after screening for strains with increased sensitivity to
nitrogen mustard and 8-methoxypsoralen plus UVA light, re-
spectively (25, 48). Some of the mutants isolated are sensitive
to several classes of DNA-damaging agents, while others are
almost exclusively sensitive to ICL agents. The gene mutated in
one of these strains is SNM1, which is allelic with PSO2 and
encodes a nuclear 76-kDa protein (9, 23, 47). snm1 mutants are
sensitive to a number of agents that cause ICLs, but they are
only mildly sensitive to monofunctional alkylating agents and
254-nm UV light (UV254 nm) and are not hypersensitive to
gamma rays (6, 25, 49). In exponentially growing cells, the
expression of SNM1 can be induced by ICL agents or UV254 nm
(61). Overexpression of SNM1 results in an increased resis-
tance to nitrogen mustard and cisplatin (22).
Many genes involved in DNA damage repair are conserved
between yeast and higher eukaryotes. One way to elucidate the
mechanisms of ICL repair in mammalian cells is by studying
mammalian homologs of Saccharomyces cerevisiae genes spe-
cifically involved in ICL repair. A human homolog of SNM1
has been isolated, and a comparison of its predicted protein
product (hSnm1) to S. cerevisiae Snm1 (ScSnm1) has revealed
39% similarity, excluding gaps (43). The gene is located on
chromosome 10q25, a region often found to be rearranged in
tumors (4, 52, 58). Here, we report on the characterization of
mammalian SNM1 homologs.
MATERIALS AND METHODS
hSNM1 cDNA constructs. The cDNA of human SNM1 (hSNM1) (kindly pro-
vided by N. Nomura) was used to make several constructs containing tags at the
59 and 39 termini of hSNM1 (Table 1). For this purpose, the 59 terminus of
hSNM1 was modified to generate an XhoI restriction enzyme site just in front of
the expected initiation codon, thereby deleting the 900-bp 59 untranslated region
that contains 15 additional ATG sequences. The following tags were added to
hSnm1: an N-terminal histidine tag (His10; single-letter amino acid code: MGH
HHHHHHHHHGGSR), a C-terminal hemagglutinin tag (HA; PGGYPYDVP
DYAS), and a C-terminal histidine-hemagglutinin tag (PHHHHHHGGSAYPY
DVPDYAS). Parts of the hSNM1 cDNA were subcloned into pEGFPC vectors
(expressing green fluorescent protein [GFP]; Clontech) (Table 1).
Subcellular localization of hSNM1. The constructs GFP-hSNM1, GFP-
570hSNM1, GFP-1515hSNM1, and GFP-ChSNM1 were transfected into CHO9
cells. To obtain stable transfectants, cells were split after 1 day and subjected to
G418 selection (1 mg/ml). Single colonies expressing GFP-hSnm1 proteins were
expanded. The GFP-hSNM1 construct was also microinjected into multinucle-
ated fibroblasts according to previously described procedures (27).
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Generation of anti-hSnm1 antibodies. A 354-bp PstI-HindIII fragment from
the hSNM1 cDNA was subcloned into pTrcHisC (Table 1). The fusion protein
derived from this plasmid contained amino acids 644 to 763 of hSnm1 fused to
a His6 tag and was produced in Escherichia coli strain DH5a. The protein was
present in the insoluble fraction and was dissolved in 6 M urea. It was purified
on a Ni-nitrilotriacetic acid column, eluted with 200 mM imidazole, and used to
immunize two rabbits. The detection limit of the polyclonal antibodies was
determined by immunoblotting using a range of 1 to 1,000 ng of antigen and was
shown to be below 1 ng. The antibodies were affinity purified using fusion protein
immobilized on a nitrocellulose filter.
Expression of recombinant hSnm1. The cDNA encoding His10-hSnm1-HA
was subcloned into pFastBac1 (GibcoBRL) (Table 1). The resulting plasmid was
used to create recombinant viruses and to produce the protein in Sf21 cells as
described by the manufacturer. Protein extracts of these cells were made as
described previously (54).
Construction of mSNM1 targeting vectors. A mouse testis cDNA library was
hybridized with a 2.7-kb EcoRI hSNM1 cDNA fragment. The resulting murine
SNM1 (mSNM1) cDNA clone was sequenced and used to screen a lambda phage
genomic library made from mouse strain 129/Sv. Genomic fragments hybridizing
to the mSNM1 cDNA were subcloned in pBluescript II KS (Stratagene). The
locations and intron and exon borders of the first five exons were determined by
restriction analysis and DNA sequencing. Targeting constructs were made by
cloning a 4-kb SalI fragment encompassing exons 2 and 3 and a 5-kb HindIII
fragment encompassing part of exon 4 and exons 5 to 7 in pBluescript II KS.
Between these fragments, a cassette containing either a neomycin (neo) resis-
tance gene or a hygromycin (hyg) resistance gene was inserted. This step resulted
in the partial deletion of exon 4. These targeting constructs are referred to as
mSNM1neo and mSNM1hyg, respectively (Table 1) (see Fig. 3A).
ES cell culture and electroporation. Embryonic stem (ES) cells were electro-
porated with the mSNM1hyg targeting construct and cultured on gelatinized
dishes as described previously (17). The cells were split 24 h after electropora-
tion, and hygromycin B was added to a final concentration of 200 mg/ml. After 7
to 10 days, colonies were isolated and expanded. Genomic DNA from individual
clones was digested with SpeI or HindIII and analyzed by DNA blotting using the
flanking exon 1 probe (see Fig. 3A). DNA from targeted clones with the expected
hybridization pattern was subsequently digested with SspI and hybridized with
the internal intron 5 probe to confirm proper homologous integration. To obtain
ES cell lines carrying a disruption in both mSNM1 alleles, an mSNM1hyg-targeted
ES cell line was electroporated with the mSNM1neo targeting construct. After
selection with G418 (200 mg/ml) for 7 to 11 days, colonies were isolated and
expanded. The isolated DNA was digested with HindIII and hybridized with exon
1 DNA to identify cell lines containing two targeted mSNM1 alleles.
Rescue of mSNM12/2 cells by hSNM1 cDNA constructs. The hSNM1-HA
cDNA was subcloned into pPGK-p(A) to express the gene under the control of
the phosphoglycerate kinase (PGK) promoter (Table 1). This cDNA expression
construct was coelectroporated with a puromycin-expressing plasmid into
mSNM1neo/hyg cells. Clones were selected with puromycin (1 mg/ml) for 10 days.
Integration of the cDNA construct was confirmed by DNA blotting.
Rescue of mSNM12/2 cells by mSNM1 genomic constructs. A GFP-mSNM1
targeting fusion construct was made under the control of the mSNM1 promoter
(see Fig. 3B). To obtain the expression of mSNM1 with 39-terminal GFP, the 39
terminus of mSNM1 cDNA was modified by PCR to create an EcoRV site in
front of the stop codon. In this site, the GFP cDNA was cloned, and the borders
were sequenced. Then, the 5.6-kb genomic mSNM1 HindIII fragment encom-
passing exons 1 to 4 was cloned into the cDNA, thereby fusing exon 4 from the
genomic fragment with cDNA exons 4 to 9. Behind the endogenous polyadenyl-
ation signal, a neo cassette and the 5-kb mSNM1 HindIII fragment were cloned
(see Fig. 3B). The construct, named mSNM1C-GFP, was transfected into
mSNM1hyg-targeted ES cells, and clones were selected with G418 (200 mg/ml)
and expanded. The isolated DNA was digested with SspI and hybridized with the
intron 5 probe to screen for cell lines containing the homologously integrated
target DNA.
Cell survival assays. The sensitivity of ES cells to increasing doses of DNA-
damaging agents was determined by measuring their colony-forming ability as
described before (17). The cloning efficiency of untreated cells varied between 10
and 30%. Cells were incubated in drug-containing media for 1 h. Sensitivity to
8-methoxypsoralen plus UVA light was determined as follows. Dishes were
incubated for 30 min in medium with 8-methoxypsoralen in the dark. Then, the
cells were irradiated with 12 kJ of 320- to 380-nm UVA light at 2 mW/cm2 in
phosphate-buffered saline containing 8-methoxypsoralen. All measurements
were performed in triplicate.
Miscellaneous methods. Reverse transcription (RT)-PCR, immunofluores-
cence microscopy, generation of mSNM1 mutant mice, and in vivo MMC survival
assays were performed according to standard procedures and as previously de-
scribed (17, 18, 55).
RESULTS
Comparison of Snm1 from different species. A database
search using either ScSnm1 or hSnm1 as a query sequence
revealed the existence of homologs of Snm1 in many different
species, including Schizosaccharomyces pombe, Aspergillus ni-
ger, Arabidopsis thaliana, Caenorhabditis elegans, Drosophila
melanogaster, Danio rerio, and Rattus norvegicus (Fig. 1). We
isolated and sequenced the mouse homolog (mSnm1) as de-
scribed below. In addition, we identified part of a second hu-
man and mouse Snm1 homolog that we refer to as hSnm1B or
mSnm1B, respectively, and a third human Snm1 homolog,
called hSnm1C. Comparison of these different mammalian ho-
mologs showed that hSnm1 and mSnm1 displayed the highest
degree of similarity to ScSnm1. hSnm1B and mSnm1B showed
a high degree of similarity to each other but less similarity to
ScSnm1. In A. thaliana, three Snm1 homologs were also found,
but these were not clear homologs of hSnm1, hSnm1B, or
hSnm1C. The length of the protein varied between different
homologs and species. Some homologs showed similarity in the
N-terminal region of Snm1, including the putative Zn finger
domain present in ScSnm1. Other homologs did not contain
this Zn finger domain and showed no significant similarity in
the N-terminal region. Deletion of the Zn finger in S. cerevisiae
did not render cells more sensitive to nitrogen mustard (23).
The middle part of the protein was least conserved among all
species, while conservation was highest in the C-terminal re-
gion. Eight regions stood out in particular, and we refer to
these as motifs (Fig. 1). However, because these motifs ap-
peared unique for Snm1, no clues regarding their function
could be obtained through database searches.
Subcellular localization of hSnm1. The subcellular localiza-
tion of hSnm1 was determined by microinjecting human fibro-
blasts and by transfecting CHO9 cells with a GFP-hSNM1 fu-
sion construct (Table 1 and Fig. 2). As a control, the pEGFPC2
vector was transfected. In this case, GFP was diffusely present
throughout the cell. In contrast, the location of GFP-hSnm1
was clearly restricted to the nucleus after both microinjection
TABLE 1. Characteristics of the mammalian SNM1 constructs
Construct Vector Gene Tag(s)a
hSNM1-HA pPGK-p(A) hSNM1 cDNA HA
His-hSNM1-HA pFastBac1 hSNM1 cDNA His10, HA
GFP-hSNM1 pEGFPC2 hSNM1 cDNA GFP, His6HA
GFP-570hSNM1 pEGFPC3 hSNM1 cDNA bp 1–570 GFP
GFP-1515hSNM1 pEGFPC2 hSNM1 cDNA bp 1–1515 GFP
GFP-ChSNM1 pEGFPC3 hSNM1 cDNA bp 1652–3123 GFP, His6HA
TrcHis-hSNM1 pTrcHisC hSNM1 cDNA bp 1930–2285 His6
mSNM1neo pBluescript II KS mSNM1 genomic disruption NA
mSNM1hyg pBluescript II KS mSNM1 genomic disruption NA
mSNM1C-GFP pBluescript II KS mSNM1-genomic cDNA fusion GFP
a NA, not applicable.
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and transfection, as revealed by inspection of the cells under a
fluorescence microscope after one to several days (data not
shown). GFP-hSnm1 was excluded from the nucleolus. In cells
expressing large amounts of protein, there was also weak stain-
ing of the cytoplasm. We conclude that hSnm1 is a nuclear
protein. A few days after transfection or microinjection, many
of the cells expressing large amounts of GFP-hSnm1 under-
went morphological changes that were consistent with apopto-
sis. This finding indicates that Snm1 could be toxic when over-
expressed in cells; this notion would also explain why extensive
attempts to generate stable protein-expressing clones after
G418 selection failed. Transfection of a series of GFP-hSNM1
fusion constructs revealed that the hSnm1 nuclear localization
signal is located within the N-terminal 190 amino acids, which
corresponds to the potential sequence for the nuclear localiza-
tion signal at about amino acid 20 (Fig. 2).
Generation of mSNM1-disrupted mouse cells. Screening of a
mouse testis cDNA library with the hSNM1 cDNA yielded a
mouse cDNA clone spanning the 39-terminal 2 kb of mSNM1.
This clone was sequenced and used as a probe to obtain
genomic mouse DNA. Two clones that spanned the first seven
exons of the mSNM1 genomic locus were obtained. The locus
was characterized by restriction site mapping, PCR, and se-
quencing of the first two exons (Fig. 3A). A targeting construct
was made by subcloning into pBluescript II KS a 4-kb SalI
fragment encompassing exons 2 and 3 and a 5-kb HindIII
fragment encompassing part of exon 4 and exons 5 to 7 with a
selectable marker gene in between. In this way, part of intron
FIG. 1. Comparison of the deduced amino acid sequences of SNM1 homologs. The amino acid sequences of the C termini of S. cerevisiae (Sc), A. thaliana (At),
mouse (m), and human (h) Snm1 are aligned and shown in the single-letter code. The second human and mouse Snm1 homologs, called Snm1B, and the third human
homolog, called Snm1C, are incomplete. A more extensive version of this figure, including Snm1 homologs from additional species, can be found at http://www.eur.nl/
fgg/ch1. Identical and similar amino acids are shown in black and gray boxes, respectively. Dots denote gaps; question marks denote unknown sequences. Amino acid
positions are shown on the left. The eight motifs with high conservation are underlined. GenBank accession numbers are X64004 (S. cerevisiae), X98130 (A. thaliana),
D42045 (human), AL137856 (hSnm1B), AA315885 and AA306797 (hSnm1C), AF241240 (mouse), and AI530740 and AI503687 (mSnm1B).
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3 and 25 bp of exon 4 were deleted. This procedure resulted in
elimination of the C-terminal 287 amino acids of mSnm1,
which contain most of the conserved motifs (Fig. 1). Moreover,
aberrant RNA splicing that skips the targeted exon would
result in a frameshift mutation. Disruption constructs were
made containing the neo or the hyg selectable marker gene
(mSNM1neo and mSNM1hyg, respectively).
The mSNM1hyg construct was electroporated into ES cells.
Four independent cell lines containing one disrupted mSNM1
allele were identified by DNA blotting. The second wild-type
allele was disrupted by targeting with the mSNM1neo construct.
Three double-knockout cell lines in which the remaining wild-
type allele was replaced by mSNM1neo were obtained (data not
shown).
RT-PCRs with RNAs isolated from mSNM11/2 and
mSNM12/2 cells were performed using primers for exons 2
and 7. RNA from mSNM11/2 cells showed a clear signal from
the wild-type mSNM1 allele, and both cell lines showed three
weak signals from the knockout allele (data not shown). These
three bands were cloned and sequenced. One product would
result in a frameshift and a premature stop codon. The other
two products, one containing an insert from the neo cassette
and the other splicing around exon 4, used an alternative splice
site in exon 5 which restored the reading frame. Both would
result in disruption of conserved motifs 2 and 3 of mSnm1
(Fig. 1). No significant difference in growth rate between
mSNM11/1 ES cells and all mSNM11/2 and mSNM12/2 cell
lines was detected. We conclude that, similar to the situation
for S. cerevisiae, disruption of mSNM1 in mouse cells results in
viable cells (47).
mSNM12/2 ES cells are sensitive to MMC. S. cerevisiae
snm1 mutants are sensitive to DNA ICL agents but not to
gamma rays and only slightly to UV light (25, 49). We there-
fore investigated the effects of these DNA-damaging agents
on the survival of mSNM12/2 ES cells. These cells were
found to be approximately twofold more sensitive to MMC
than mSNM1-proficient cells, which were otherwise isogenic
(Fig. 4A). There was no difference between mSNM11/1 and
mSNM11/2 cells. In contrast, we did not find any significant
sensitivity to 8-methoxypsoralen plus UVA, cisplatin, melpha-
lan, UV254 nm, methyl methanesulfonate, and gamma rays (Ta-
ble 2). As a control, ERCC12/2 ES cells were also treated with
these agents and found to be sensitive to UV254 nm and all ICL
agents tested (Table 2), as expected from the behavior of
FIG. 2. Subcellular localization of hSnm1. Schematic representation of the
different GFP-hSNM1 fusion constructs transfected into CHO9 cells. The upper
line shows the hSNM1 cDNA with the putative nuclear localization signal (NLS),
the Zn finger, and the conserved motifs. Below are the different hSNM1 con-
structs tagged with 59-terminal GFP and the localization of their fluorescence
signal in the cells (2, absent; 1 through 111, present in increasing amounts).
FIG. 3. Characterization of the mSNM1 genomic locus and generation of mSNM1 knockout and knockin constructs. The first seven exons are indicated by boxes.
The lines below exon 1 and intron 5 indicate the positions of the probes used to screen for the disrupted alleles and the presence of the knockin allele. The locations
of selected restriction sites are shown. (A) Schematic representation of part of the genomic mSNM1 locus and the gene targeting constructs. The top line represents
part of the mSNM1 locus. The middle lines represent the targeting constructs and show the positions of the selectable marker genes for neomycin (neo) and hygromycin
(hyg) in exon 4, indicated by the arrows. The bottom line represents the disrupted genomic locus. (B) Genomic construct for the rescue of mSNM12/2 cells. The
genomic-cDNA mSNM1 fusion construct containing a GFP tag (hatched box) is shown. mSNM1 cDNA is represented by a white box, and the neo selectable marker
gene is represented by an arrow.
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ERCC12/2 mouse embryonic fibroblasts and ERCC1 mutant
CHO cells (14). ERCC12/2 cells were not sensitive to methyl
methanesulfonate and gamma rays (Table 2).
To prove that the phenotype of the mSNM12/2 ES cells was
caused exclusively by the disruption of mSNM1, cDNA rescue
experiments were performed. mSNM1neo/hyg cells were electro-
porated with a cDNA construct expressing HA-tagged hSnm1
together with a plasmid expressing the dominant selectable
marker for puromycin. Puromycin-resistant cell lines that had
integrated hSNM1-HA were fully corrected for the MMC sen-
sitivity of mSNM12/2 ES cells (Fig. 4B).
mSNM1 is expressed at low levels in ES cells. To investigate
the expression of mSNM1 in ES cells, we generated a GFP-
tagged version of mSNM1 under the control of the endogenous
mSNM1 promoter (Fig. 3B and Table 1). For this purpose,
a targeting construct, mSNM1C-GFP, was made by cloning
mSNM1 cDNA exons 4 to 9 with 39-terminal GFP behind
genomic exon 4. As a consequence, the mRNA consisted of
a fusion of four genomic exons and the cDNA with 39-ter-
minal GFP and was transcribed under the control of the en-
dogenous mSNM1 promoter. mSNM1C-GFP was transfected
into mSNM11/2 ES cells, and clones containing tagged and
knockout mSNM1 alleles were obtained.
mSNM1C-GFP was expressed and functional, because the
MMC sensitivity of mSNM12/2 ES cells was complemented by
the presence of mSNM1C-GFP (Fig. 4C). Amplification by RT-
PCR using an mSNM1 primer and a GFP primer spanning at
least one intron revealed the expression of mSNM1C-GFP at the
RNA level (data not shown). However, fluorescence micros-
copy failed to detect the GFP signal. Given the detection limit,
this result implies that there are less than 10,000 molecules of
mSnm1 per cell (45). We were also unable to detect either
endogenous or transfected mSnm1 by immunoblot analysis
with anti-GFP (Clontech) and anti-hSnm1 antibodies, even
though anti-hSnm1 antibodies were highly sensitive, with a
detection limit of about 5,000 Snm1 molecules per cell (data
not shown). We cannot exclude the possibility, however, that
our anti-hSnm1 antibodies were unable to recognize mSnm1.
Similarly, we tried to detect the presence of hSnm1-HA ex-
pressed under the control of the PGK promoter in mSNM12/2
ES cells; this construct can rescue the MMC sensitivity of these
cells (Fig. 4B). Although both anti-hSnm1 and anti-HA anti-
bodies recognized the protein when it was overproduced in
Sf21 cells, we could not detect the protein in ES cells by ei-
ther immunoblot or immunofluorescence microscopy (data not
shown). Taken together, these results indicate that Snm1 pro-
tein levels in ES cells are very low, even when the protein is
FIG. 4. Effect of MMC on wild-type and mutant mSNM1 ES cells. ES cells
were treated with MMC for 1 h (see Materials and Methods). All measurements
were performed in triplicate. (A) Clonogenic survival of mSNM11/2 and
mSNM12/2 ES cells after treatment with increasing concentrations of MMC. (B)
Rescue of the MMC sensitivity of mSNM12/2 cells by hSNM1-HA. An mSNM12/2
cell line containing randomly integrated hSNM1-HA cDNA expression con-
structs was obtained as described in Materials and Methods. The survival of this
cell line was compared to the survival of mSNM11/1 and mSNM12/2 ES cells.
(C) Rescue of the MMC sensitivity of mSNM12/2 cells by mSNM1C-GFP. Two
mSNM1C-GFP/2 cell lines were obtained as described in Materials and Methods.
The survival of these cell lines was compared to the survival of mSNM11/2 and
mSNM12/2 ES cells. Error bars represent standard errors of the mean. Numbers
following symbol definitions (figure insets), cell line isolation number.
TABLE 2. Sensitivity of mSNM12/2 and ERCC12/2





MMC 0.1–1.6 mg/ml Sens Sens
Melphalan 0.5–12 mM Wt ND
8-Methoxypsoralen plus
UVA light
0.1–100 ng/ml Wt Sens
Cisplatin 0.25–4 mg/ml Wt Sens
Gamma rays 1–8 Gy Wt Wt
Methyl
methanesulfonate
1–2.5 mM Wt Wt
UV254 nm 2–12 J/m
2 Wt Sens
a Wt, sensitivity equal to that of wild-type cells; Sens, sensitivity higher than
that of wild-type cells; ND, sensitivity not determined.
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expressed under the control of the relatively strong PGK pro-
moter.
Generation of mSNM12/2 mice. The experiments described
above show that disruption of mSNM1 is compatible with nor-
mal ES cell growth. Subsequently, we investigated whether
mSnm1 is required for normal mouse development. Cells from
four targeted ES clones, carrying the mSNM1hyg allele, were
injected into C57BL/6 blastocysts, and 11 chimeric mice were
obtained. The disrupted mSNM1 allele was transmitted to the
mouse germ line. F1 heterozygous offspring were intercrossed,
and F2 offspring were genotyped by DNA blotting, PCR anal-
ysis, or both (data not shown). Among 78 genotyped animals,
20 mSNM11/1, 30 mSNM11/2, and 28 mSNM12/2 animals
were identified. This outcome is compatible with normal Men-
delian segregation of the disrupted mSNM1 allele. Thus, dis-
ruption of mSNM1 does not result in embryonic or neonatal
lethality. No statistically significant difference in weight was
observed among mSNM11/1, mSNM11/2, and mSNM12/2 lit-
termates (data not shown). Importantly, the mSNM12/2 mice
exhibited no macroscopic abnormalities up to at least 12
months of age. Both mSNM12/2 males and females were fer-
tile.
mSNM12/2 mice are sensitive to MMC. We tested whether
the sensitivity of mSNM12/2 ES cells to the DNA ICL agent
MMC was also found in mSNM12/2 mice. mSNM11/2 and
mSNM12/2 mice were treated with various doses of MMC,
ranging from 7.5 to 15 mg/kg of body weight. Injection of 10
and 15 mg/kg in female mice resulted in enhanced sensitivity in
mSNM12/2 mice (Fig. 5). In addition, with 15 mg/kg, a shorter
latency period in mSNM12/2 mice was observed. In male mice,
7.5 mg/kg was lethal for 30% of the knockout mice, while
all heterozygous mice survived. At 10 mg/kg, only 10% of
the mSNM12/2 mice survived treatment, while 70% of the
mSNM11/2 mice survived (Fig. 5). These results show that
the hypersensitivity to MMC found in mSNM12/2 ES cells is
also present in mSNM12/2 mice.
DISCUSSION
Characterization of mammalian SNM1. We have analyzed
mammalian homologs of the S. cerevisiae SNM1 gene, which
specifically provides resistance to ICL agents. Like yeast snm1
knockout cells, mSNM12/2 ES cells and mice are viable, show-
ing that SNM1 is not essential for viability (21). The mice do
not show any major abnormalities and are fertile. mSNM12/2
ES cells and mice are sensitive to MMC, but the cells are not
sensitive to UV254 nm, methyl methanesulfonate, or gamma
rays, in agreement with the results obtained with S. cerevisiae
snm1 cells (25, 49). These results argue for a specific role of
mammalian SNM1 in the cellular response to ICL agents,
similar to the role of yeast SNM1.
hSnm1 resides in the nucleus (Fig. 2), similar to its yeast
homolog, a location expected for a DNA repair protein (23). It
has a putative nuclear localization signal at the N terminus,
and there may be another signal in the C terminus of the
protein. The gene is expressed in all tissues tested (43). hSNM1
contains an exceptionally long, 911-bp 59-terminal untranslated
region, containing several ATGs in all reading frames, which
FIG. 5. MMC sensitivity of mSNM12/2 mice. Shown are survival curves for mSNM11/2 and mSNM12/2 mice after a single intraperitoneal injection of the indicated
amounts of MMC. (A) Survival of 12 mSNM11/2 and 8 mSNM12/2 female mice after injection with a dose of 10 mg of MMC per kg. (B) Survival of 11 mSNM11/2
and 5 mSNM12/2 female mice after injection with 15 mg of MMC per kg. (C) Survival of 6 mSNM11/2 and 7 mSNM12/2 male mice after injection with 7.5 mg of
MMC per kg. (D) Survival of 16 mSNM11/2 and 9 mSNM12/2 male mice after injection with 10 mg of MMC per kg.
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might cause inefficient translation. We could not detect any
hSnm1-HA or mSnm1-GFP after transfection into mSNM12/2
cells, although the detection limit of our antibodies was below
1 ng and the fluorescence microscopy detection limit of GFP is
about 10,000 molecules per cell (45). This result suggests that
the level of expression of Snm1 is very low, in agreement with
the codon usage and the lack of a TATA box. S. cerevisiae
SNM1 is also expressed at a very low level (47). Nevertheless,
we could complement the MMC sensitivity of mSNM12/2 cells
with hSnm1-HA and mSnm1-GFP; thus, the protein levels
must have been sufficient, and the HA and GFP tags at the C
terminus of Snm1 must not have interfered with its function.
Cross-link repair pathways. The formation and repair of
ICLs in cells are complex processes, with major differences
between ICL agents. The sensitivity of a cell to a certain ICL
agent is dependent on all steps in the processing of ICLs,
ranging from uptake and metabolization to damage recogni-
tion and repair (6). A number of major DNA damage repair
pathways are involved in the repair of ICLs. In S. cerevisiae,
mutants in the nucleotide excision repair (NER), recombina-
tion repair, and translesion repair pathways are sensitive to
ICL agents (24). Moreover, a number of ICL-sensitive mu-
tants, such as pso2 to pso4 mutants, do not quite fit into one of
these pathways (23). The major repair pathway of ICLs in
S. cerevisiae is supposed to start with incision by the NER
system, resulting in a DNA double-strand break (DSB), in
contrast to the incision in E. coli, which does not result in a
DSB (13, 28, 40, 59). The DSB can be repaired by the recom-
bination repair pathway (2, 28). Repair may also occur via the
translesion repair pathway, involving RAD6 and RAD18 (51).
Yeast translesion repair pathway mutants are not defective in
the repair of an ICL on a plasmid, in contrast to recombination
repair pathway mutants, suggesting that chromatin structure
can have an important influence (39). On the other hand,
rad52 mutants, which are impaired in recombination repair,
are hardly sensitive to nitrogen mustard, suggesting that the
repair pathway used may depend on the ICL agent (51).
In mammals, a large number of mutant cell lines are known
to be sensitive to ICL agents (11). Many of the known mutated
genes in those cell lines belong to the NER pathway, the
recombination repair pathway, and/or the error-prone postrep-
lication repair pathway (11, 17, 32). A number of genes cannot
be attributed to one of the known repair pathways (7, 11). The
molecular mechanisms of mammalian ICL repair are still un-
known, but they are probably similar to those of S. cerevisiae
and E. coli ICL repair. Incision of the ICLs is supposed to be
performed by some of the NER proteins, as mutations in
ERCC1 result in a decrease in the incision of ICLs and reduced
repair-associated replication (35). In contrast to the situation
in S. cerevisiae, where no significant differences among NER
mutants are found, most mammalian NER-deficient cells
are only moderately sensitive to ICL agents (11). However,
ERCC1/XPF mutants are among the most MMC-sensitive cell
lines. Therefore, in addition to their role in NER, ERCC1 and
XPF are likely to be involved in the incision of ICLs or subse-
quent recombination, independent of the other NER genes.
The sensitivity of the other NER mutants might be caused
solely by a defect in the repair of monoadducts. Hamster cell
lines with an MMC sensitivity similar to that of ERCC1 mu-
tants are irs1 and irs1SF (11). The genes mutated in these cell
lines are XRCC2 and XRCC3, which are paralogs of the re-
combination repair gene RAD51 and are important for chro-
mosomal stability and DSB repair (12, 30, 37, 46, 56, 57). The
mechanism by which these genes work is still unknown, but
they could have an important role in recombination repair of
ICLs.
Another group of genes involved in the response to ICL
agents consists of the Fanconi anemia (FANC) genes. FANC is
characterized by developmental abnormalities, pancytopenia
of blood cells, and a predisposition to cancer (16). FANC cells
are sensitive to ICL agents and to oxidative DNA damage and
show cell cycle abnormalities (7). To date, eight complemen-
tation groups have been found, and three genes have been
cloned, FANCA, FANCC, and FANCG (15, 19, 29, 38, 53).
FANCC knockout mice are very sensitive to MMC, although
otherwise, their phenotype is very mild (8, 10, 60). The possi-
bility that SNM1 is one of the remaining FANC genes cannot
be excluded.
Role of Snm1 in ICL repair. The results for S. cerevisiae
SNM1 show that Snm1 is not required for all ICL repair. S.
cerevisiae snm1 cells show synergism with mutants from both
the translesion and the recombination repair pathways with
regard to sensitivity to ICL agents, suggesting that Snm1 func-
tions in an alternative pathway (24, 51). Moreover, snm1 cells
are capable of repairing an ICL on a plasmid, suggesting that
the activity of Snm1 may be related to the modulation of
chromosomal structure (39). The sensitivity of snm1 mutants
to all ICL agents tested suggests that Snm1 is involved in an
ICL agent-independent step and therefore probably after the
formation of ICLs (6, 25, 49). This notion is consistent with the
fact that snm1 mutants are capable of creating DSBs after
treatment with 8-methoxypsoralen plus UVA light, in contrast
to NER mutants, which are not able to incise the DNA near
the ICL (40, 42). snm1 mutants are, however, epistatic with
NER mutants, suggesting that they play a role in this repair
pathway (24, 51). Snm1 may be involved in restoring the con-
tinuity of the DNA, because snm1 cells are not able to repair
the DSBs formed (40). Alternatively, Snm1 could also play a
more indirect role, in the regulation of ICL repair.
mSNM1 knockout ES cells are specifically sensitive to MMC
but not to cisplatin, melphalan, or 8-methoxypsoralen plus
UVA light, in contrast to S. cerevisiae snm1 cells. Therefore,
mammalian SNM1 is probably not essential for a general ICL
repair pathway. Mammalian cells could have different proteins
for the recognition and repair of different ICLs, while yeast
cells could depend on a single protein. Alternatively, some
translesion repair pathways in mammals could be more effi-
cient than those in yeast, taking over most ICL repair in
mSNM1 knockout ES cells but being insufficient to repair
MMC-induced ICLs. We cannot exclude the possibility of the
presence in our knockout ES cells of some mutated mSnm1
that could fulfill some of the functions of the protein and
thereby mitigate the phenotype. However, this notion is not a
likely explanation of the mild phenotype, because two highly
conserved motifs were deleted. As the sequence of the protein
does not give clues to its function, we can only speculate about
its role. mSnm1 could be involved in the activation of MMC,
decreasing the number of ICLs or other damage caused by this
agent. Alternatively, it could be responsible for the recognition
of MMC-induced ICLs and other structurally related ICLs.
These explanations would be inconsistent with the yeast snm1
phenotype, although a direct comparison is not possible be-
cause of the existence of multiple mammalian SNM1 homologs
and because MMC has not been tested in S. cerevisiae. It is also
possible that Snm1 is involved in a regulatory pathway, influ-
encing the response of the cell to the damage caused by MMC.
The most attractive assumption for the function of mSnm1 is a
direct role in the repair of ICLs, as suggested by the results for
its homolog in S. cerevisiae.
Induction of mouse Rad51 foci is normal in mSNM12/2 cells.
In S. cerevisiae, snm1 and rad52 mutants are synergistic with
respect to treatment with ICL agents (24, 51). The RAD52
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group of recombination repair genes, of which the main mem-
bers are RAD51, RAD52, and RAD54, is also involved in ICL
repair in mammals (17, 33, 44). On treatment with MMC,
mouse Rad51 forms nuclear foci (20). Immunofluorescence on
mSNM1 knockout ES cells after MMC treatment showed nor-
mal focus formation of Rad51 (data not shown). In contrast,
XRCC3 and mouse RAD54 (mRAD54) mutants do not show
Rad51 foci after treatment with cisplatin and MMC, respec-
tively (3, 55). These results suggest either that Snm1 is required
for the ICL recombination repair pathway after the involve-
ment of Rad51 or that it plays a role independent of the
recombination repair pathway.
Redundancy of mammalian Snm1 function. The relatively
mild phenotype of mSNM12/2 ES cells and mice is reminiscent
of the phenotype found for mRAD542/2 cells and mice, which
are also about twofold more sensitive to MMC than wild-type
cells and mice (17, 18). This mild phenotype can probably be
attributed in part to the existence of parallel pathways for the
repair of ICLs. In addition, known homologs for both mSNM1
and mRAD54 could take over part of the function (Fig. 1) (26).
In fact, redundancy is a phenomenon that is quite common in
mammalian DNA damage repair pathways. The NER gene
RAD23, the translesion repair gene RAD6, and the recombi-
nation repair gene RAD51 have several mammalian homologs
(34, 41, 57). These duplications provide cells with the possibil-
ity of functional differentiation in the repair of different types
of damage, in different phases of the cell cycle, or in different
cell types. Moreover, the cell can fall back on the alternative
repair pathway in case of dysfunction of one of the proteins
involved, a strategy which may prevent inappropriate repair
and cell transformation. It will be important to analyze the
other SNM1 homologs and to look at the effects of ICL agents
on double knockout cells. Furthermore, study of cells with
mutations in SNM1 and other genes functioning in ICL repair,
such as mRAD54, will yield information on the relative impor-
tance of the different ICL repair pathways and the level of
redundancy between different pathways. Nevertheless, the sen-
sitivity of mSNM1 knockout cells to MMC shows that there is
no complete redundancy in mammalian cells. Both the se-
quence conservation and the functional conservation with
yeast Snm1 underline the significance of SNM1 in ICL repair.
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